NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers

Inclusion Criteria: * Male or female subjects 18-65 years of age * Has the ability to understand and has signed a written informed consent form and HIPAA authorization * Females of childbearing potential must agree to use an adequate birth control * Fitzpatrick (1988) skin type I, II, or III. Exclusion Criteria: * History of severe reactions from exposure to sunlight * Known allergies or sensitivities to adhesives in patches, medical tape, or ingredients found in the test articles * Inability to evaluate the skin in and around the test sites * Diabetes requiring medication * Clinical significant skin diseases which may contraindicate participation * Asthma or any other severe respiratory disease requiring chronic medication * Known immunological disorders such as HIV, AIDS, SLE and/or RA * History, within the last six months, of current cancer, including skin cancer * Mastectomy for cancer removal of lymph nodes draining test sites * Epilepsy * Pregnancy, lactation, or planning a pregnancy during the test period * Chronic use of systemic antihistamine medication, or use within 14 days prior to Screening Visit * Use of anti-inflammatory drugs (exception: acetaminophen and \< 81 mg.day aspirin are permitted) within 2 days of Screening Visit * Currently receiving allergy injections * Currently taking or expecting to take any photosensitizing medications * Use of immunosuppressive drugs * Topical drugs used at the test sites within the last 7 days prior to screening * Current participation in any clinical trial * Participation in any patch test for irritation or sensitization or any test involving UV exposures within 4 wees of study start * Use of any investigational therapy within the past 4 weeks.